MedTrace Logo

Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).

NCT07107022 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-04-27

No results posted yet for this study

Summary

The primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)

Conditions

  • Acute Ischemic Stroke (AIS)

Interventions

DEVICE

Penumbra System ®

Neurovacular Mechanical Thrombectomy with the Penumbra System®

Sponsors & Collaborators

  • Penumbra Inc.

    lead INDUSTRY

Principal Investigators

  • Marios Nikos Psychogios, Prof MD · University Hospital of Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2027-10-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • Australia
  • France
  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07107022 on ClinicalTrials.gov